Serial changes of international prostate symptom score following I-125 prostate brachytherapy

International Journal of Clinical Oncology

Volumn 11, Issue 4, 2006, Pages 320-325

  Ohashi, Toshio ^a   Yorozu, Atsunori ^a   Toya, Kazuhito ^a   Saito, Shiro ^a   Momma, Tetsuo ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Brachytherapy; Iodine 125; IPSS; Prostate cancer; Urinary morbidity

Indexed keywords

ANTIANDROGEN; GONADORELIN; IODINE 125;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; COURSE EVALUATION; DOSIMETRY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MONOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GONADOTROPIN-RELEASING HORMONE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROSTATE; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; RESEARCH DESIGN; URINATION DISORDERS;

EID: 33748094619     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0584-3     Document Type: Article

References (20)

1. GS Merrick K Wallner WM Butler 2003 Permanent interstitial brachytherapy in the management of carcinoma of the prostate gland J Urol 169 1643 1652
2. GS Merrick K Wallner WM Butler 2003 Minimizing prostate brachytherapy-related morbidity Urology 62 786 792
3. BH Han KC Demel K Wallner 2001 Patient reported complications after prostate brachytherapy J Urol 166 953 957
4. MJ Barry FJ Fowler MP O'Leary 1992 The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1549 1557
5. E Barnboym A Ahrens CG Roehrborn 1999 Effective scrambling on the short-term reliability of the American Urological Association symptom index Urology 53 568 573
6. MD Terk RG Stock NN Stone 1998 Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate J Urol 160 1379 1382
7. T Ohashi A Yorozu K Toya 2005 Acute urinary morbidity following I-125 prostate brachytherapy Int J Clin Oncol 10 262 268
8. D Fleming American Joint Committee on Cancer, National Cancer Institute (U.S.) 1997 AJCC cancer staging manual Lippincott-Raven Philadelphia
9. 125I prostate brachytherapy as monotherapy Int J Radiat Oncol Biol Phys 53 588 594
10. K Toya A Yorozu T Ohashi 2005 Experience of brachytherapy using I-125 seed permanent implants for localized prostate cancer Nippon Acta Radiol 65 432 437
11. FA Vicini VR Kini G Edmundson 1999 A comprehensive review of prostate cancer brachytherapy: defining an optimal technique Int J Radiat Oncol Biol Phys 44 483 491
12. GS Merrick WM Butler JH Life 2000 Temporal resolution of urinary morbidity following prostate brachytherapy Int J Radiat Oncol Biol Phys 47 121 128
13. J Crook M [tmp] McLean C Catton 2002 Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation Int J Radiat Oncol Biol Phys 52 453 460
14. DY Gelblum L Potters R Ashley 1999 Urinary morbidity following ultrasound-guided transperineal prostate seed implantation Int J Radiat Oncol Biol Phys 45 59 67
15. WR Lee MC Hall RP Mcquellon 2001 A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy Int J Radiat Oncol Biol Phys 51 614 623
16. 125iodine transperineal prostate brachytherapy Radiother Oncol 73 33 38
17. VE Arterbery A Frazier P Dalmia 1997 Quality of life after permanent prostate implant Semin Surg Oncol 13 461 464
18. MJ Zelefsky D Cowen Z Fuks 1999 Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 2460 2468
19. S Mallick R Azzouzi L Cormier 2003 Urinary morbidity after 125 I brachytherapy of the prostate BJU Int 92 555 558
20. K Wallner J Roy L Harrison 1995 Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 32 465 471